News Updates
More Articles
- Executive Message: A Different Look at the Middle East
- Mental Health Apps: Regulation and Validation Are Needed
- Access to Medicines in Africa from the Pharmaceutical Regulatory Perspective
- Emerging Regulatory Trends in Asia Pacific Regulatory Reliance, Patient-Centricity, Digitalization, and Innovative Clinical Research
- Advancing Global Healthcare Through IDMP Standards Global IDMP Working Group Public Stakeholder Meeting
Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
The pandemic exposed significant disparity in the pharmaceutical global supply chain, largely due to the dependency of low- and middle-income countries (LMICs) on pharmaceutical manufacturing in more industrialized nations. To mitigate this inequity and ensure supply of medicinal products across the globe, manufacturing of medicinal products must be decentralized through establishing manufacturing sites in LMICs.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!